Filter
1291
Text search:
regulatory
control
Featured
127
605
Language
Document type
1028
104
67
38
30
13
5
3
1
1
1
Countries
61
50
47
44
41
41
38
28
28
28
27
26
26
26
23
20
20
17
16
14
14
12
12
11
11
10
10
8
8
7
7
6
6
6
6
4
4
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
606
76
73
59
46
33
12
3
Toolboxes
101
72
71
58
50
48
35
30
26
22
20
20
15
15
15
13
11
10
3
2
1
1
Building laboratory testing capacity
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Prepared as an outcome of ICMR Expert Group on Immunophenotyping of Hematolymphoid Neoplasms | Coordinated by Division of Non Communicable Diseases | This document addresses on various issue related to good quality practices in laboratory work up of flow cytometric immunophenotyping and will be of u
...
Key considerations for the use of law to prevent noncommunicable diseases in the WHO European Region
Report of an intensive legal training and capacity-building workshop on law and noncommunicable diseases (Moscow, 30 May–3 June 2016)
The report summarizes important issues, themes and topics discussed during the meeting in Moscow, ranging from the design and implementation of legislation, reconc
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial
...
Bull World Health Organ 2017;95:594–598
District Level M & E Training and Reference Material for Primary Health Care Programmes
District Level M & E Training and Reference Material for Primary Health Care Programmes
